Fortus Medical Overview

  • Founded
  • 2011
Founded
  • Status
  • Private
  • Latest Deal Type
  • Early Stage VC
  • Latest Deal Amount
  • $500K
Latest Deal Amount
  • Investors
  • 1

Fortus Medical General Information

Description

Provider of stem cell technology designed to promote bone growth and help in the healing of spinal surgery patients. The company's technology uses stem cells to promote bone treatment in spine surgery operations, thereby enabling spinal surgery patients to heal faster and in a more painless manner.

Contact Information

Formerly Known As
Intersect7
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Healthcare Technology Systems
Primary Office
  • 700 10th Avenue South
  • Suite 119
  • Minneapolis, MN 55415
  • United States
+1 (949) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Fortus Medical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC 22-Mar-2016 $500K 00.000 Completed Startup
2. Early Stage VC 27-Mar-2014 00.000 00.000 00.000 Completed Startup
1. Seed Round 15-Dec-2011 $252K $252K 00.000 Completed Startup
To view Fortus Medical’s complete valuation and funding history, request access »

Fortus Medical Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series T 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series S 000,000 00.000000 00 00.0 00.0 00 00.0 00.000
To view Fortus Medical’s complete cap table history, request access »

Fortus Medical Patents

Fortus Medical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210251638-A1 Bone fusion system Pending 19-Feb-2020 00000000000
US-20190290344-A1 Osteomedullary tissue processing system Pending 22-Mar-2018 00000000000
EP-3634245-A1 Connective tissue progenitor cell aspiration and processing system Pending 07-Jun-2017 00000000000
EP-3634245-A4 Connective tissue progenitor cell aspiration and processing system Pending 07-Jun-2017 00000000000 0
US-20180353206-A1 Connective tissue progenitor cell aspiration and processing system Pending 07-Jun-2017 A61B17/3472 0
To view Fortus Medical’s complete patent history, request access »

Fortus Medical Executive Team (3)

Name Title Board Seat Contact Info
Robert Assell Co-Founder, President, Board Member & Chief Executive Officer
Andrew Cragg MD Co-Founder
George Wallace Co-Founder & Board Member
To view Fortus Medical’s complete executive team members history, request access »

Fortus Medical Board Members (1)

Name Representing Role Since
George Wallace Self Co-Founder & Board Member 000 0000
To view Fortus Medical’s complete board members history, request access »

Fortus Medical Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Brightstone Venture Capital Venture Capital Minority 000 0000 000000 0
To view Fortus Medical’s complete investors history, request access »